A bioequivalence study of sublingual and injectable formulations of apomorphine.
Phase of Trial: Phase I
Latest Information Update: 29 Aug 2012
At a glance
- Drugs Apomorphine (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- 29 Aug 2012 Status changed from recruiting to completed based on information reported in a Cynapsus Therapeutics media release.
- 08 Aug 2012 Results are expected in September 2012, according to a Cynapsus Therapeutics media release.
- 01 Aug 2012 Status changed from planning to recruiting.